Merck Common Stock Net 2010-2024 | MKKGY
Merck common stock net from 2010 to 2024. Common stock net can be defined as the value of common equity ownership.
- Merck common stock net for the quarter ending June 30, 2024 was $0.608B, a 1.24% decline year-over-year.
- Merck common stock net for 2023 was $0.612B, a 2.72% increase from 2022.
- Merck common stock net for 2022 was $0.595B, a 10.95% decline from 2021.
- Merck common stock net for 2021 was $0.668B, a 3.57% increase from 2020.
Merck Annual Common Stock Net
(Millions of US $) |
| 2023 |
$612 |
| 2022 |
$595 |
| 2021 |
$668 |
| 2020 |
$645 |
| 2019 |
$2,850 |
| 2018 |
$667 |
| 2017 |
$639 |
| 2016 |
$625 |
| 2015 |
$627 |
| 2014 |
$751 |
| 2013 |
$751 |
| 2012 |
$727 |
| 2011 |
$787 |
| 2010 |
$ |
| 2009 |
$ |
Merck Quarterly Common Stock Net
(Millions of US $) |
| 2024-06-30 |
$608 |
| 2024-03-31 |
$613 |
| 2023-12-31 |
$612 |
| 2023-09-30 |
$615 |
| 2023-06-30 |
$616 |
| 2023-03-31 |
$606 |
| 2022-12-31 |
$595 |
| 2022-09-30 |
$569 |
| 2022-06-30 |
$601 |
| 2022-03-31 |
$634 |
| 2021-12-31 |
$668 |
| 2021-09-30 |
$666 |
| 2021-06-30 |
$681 |
| 2021-03-31 |
$681 |
| 2020-12-31 |
$645 |
| 2020-09-30 |
$660 |
| 2020-06-30 |
$622 |
| 2020-03-31 |
$623 |
| 2019-12-31 |
$2,850 |
| 2019-09-30 |
$628 |
| 2019-06-30 |
$2,615 |
| 2019-03-31 |
$642 |
| 2018-12-31 |
$667 |
| 2018-09-30 |
$657 |
| 2018-06-30 |
$674 |
| 2018-03-31 |
$694 |
| 2017-12-31 |
$639 |
| 2017-09-30 |
$664 |
| 2017-06-30 |
$621 |
| 2017-03-31 |
$602 |
| 2016-12-31 |
$625 |
| 2016-09-30 |
$631 |
| 2016-06-30 |
$638 |
| 2016-03-31 |
$623 |
| 2015-12-31 |
$627 |
| 2015-09-30 |
$629 |
| 2015-06-30 |
$625 |
| 2015-03-31 |
$638 |
| 2014-12-31 |
$751 |
| 2014-09-30 |
$750 |
| 2014-06-30 |
$775 |
| 2014-03-31 |
$775 |
| 2013-12-31 |
$751 |
| 2013-09-30 |
$749 |
| 2013-06-30 |
$738 |
| 2013-03-31 |
$747 |
| 2012-12-31 |
$727 |
| 2012-09-30 |
$707 |
| 2012-06-30 |
$726 |
| 2012-03-31 |
|
| 2011-12-31 |
$787 |
| 2011-09-30 |
|
| 2011-06-30 |
$813 |
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
$729 |
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
